Table 2.

Comparison of important findings of various published studies with current study

Parameters	Present study	AI-Dhalimi and Aljawahiri[8]	Saraswat et al.[10]	Nyati et al.[11]	Ambika et al.[12]	Dey et al.[13]	Inakanti et al.[14]	Pal et al.[15]
Duration	1 year	1 year	4 months	1 year	1 year	1 year	2 years	6 months
Total patients	316	140	433	670	200	379	130	271
Gender distribution (F:M)	263:53	95:45	321:112	487:183	142:58	299:80	90:40	197:74
Most common age group	20-30 year	10-19 year	-	21-30 year	15-30 year	10-29 year	21-30 year	20-29 year
Most common indication	Skin lightening	Skin lightening	Face cream/fairness cream/after shave cream	Acne	Acne	Skin lightening	Fairness creams	Acne
Most common source of use	Friends/relatives	Paramedical personnel	Friend/peer/relative	Pharmacist (OTC)	Friend/peer/relative	Pharmacist/Paramedical personnel	Registered medical practitioners	Pharmacist
Most common side effect	Acne	Acne	Acne	Acneiform eruption	Acneiform eruption	Acne	Acneiform eruptions	Rosacea/photosensitivity
Most common steroid abused	Mometasone	Clobetasol	Betamethasone	Betamethasone	Betamethasone	Mixed (potent and very potent)	Betamethasone	Mid potent